| 摘要 |
The invention relates to a pharmaceutical composition comprising 0.0867 parts of dimethyl-ortho-chlorobenzyl-dodecyl ammonium chloride, 0.0867 parts of di-n-propyl-lauryl ammonium iodide, distilled water for the remainder to 100 parts, the parts being expressed by weight. The invention also relates to a method for the prophilactic and curative treatment of parvovirosis and coronavirosis in dog, said method consisting in orally administering 4 ... 15 ml of composition, depending on the weight, and age of the animal and the progress of the disease, twice a day for 3 days consecutively on curative purpose, or 1 ... 8 ml depending on the age and weight of the animal, twice a day for three days consecutively on prophilactic purpose.
|
